Healthcare -
Biotechnology - NASDAQ - US
$ 489.49
2.02 %
$ 126 B
Market Cap
-237.62
P/E
Price Target
Average
1.54%
Revenue Forecast
Estimate
11.60%
EBIT
Estimate
131.89%
Net Income
Estimate
98.50%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vertex Pharmaceuticals Incorporated
Wall Street analysts predict an average 1-year price target for VRTX of $497 , with forecasts ranging from
a
low of
$361 to a high of $600 .
VRTX Lowest Price Target
Wall Street Target
361 USD
-26.25%
VRTX Average Price Target
Wall Street Target
497 USD
1.54%
VRTX Highest Price Target
Wall Street Target
600 USD
22.58%
REVENUE FORECAST
Revenue Forecast Chart VRTX
EBIT FORECAST
EBIT Forecast Chart VRTX
NET INCOME FORECAST
Net Income Chart VRTX